Advancements in NF-1 PN Management: From Supportive Care to Cutting-Edge Therapies

Advancements in NF-1 PN Management: From Supportive Care to Cutting-Edge Therapies

Optimal treatment of neurofibromatosis type 1 (NF1)-associated plexiform neurofibromas (PN) requires nuanced, individualized treatment strategies given the diverse disease manifestations and severity. Achieving complete resection is rare, leaving patients reliant on chronic, supportive management. Mitogen-activate protein kinase (MEK) inhibitors provide a novel, targeted treatment option for reducing tumor size and patient morbidity. In this second of two videos, join two experts in a discussion covering the role and limitations of supportive care, safety and efficacy of current and emerging MEK inhibitors, and clinical implications of the latest data regarding these therapies for NF1-associated PN. You will also gain immediate access to downloadable evidence to reference in your daily practice.

  • Provider:PRIME Education, Inc. (PRIME®)
  • Activity Link: https://primeinc.org/online/advancements-nf-1-pn-management-supportive-care-cutting-edge-therapies
  • Start Date: 2024-09-11 05:00:00
  • End Date: 2024-09-11 05:00:00
  • Credit Details: AAPA Category 1 Credit™️: 0.25 hours
    AMA PRA Category 1 Credit™️: 0.25 hours
    Nursing: 0.25 hours
    Pharmacy: 0.25 hours
  • Commercial Support: Source: Springworks Therapeutics - Amount: 24875.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner/Team Competence, Learner/Team Performance
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.